Hester Biosciences
1,486.60
-28.30(-1.87%)
Market Cap₹1,264.63 Cr
PE Ratio28.78
IndustryHealthcare
Company Performance:
1D-1.87%
1M-7.38%
6M-17.64%
1Y-32.16%
5Y-13.19%
View Company Insightsright
More news about Hester Biosciences
09May 25
Hester Biosciences Declares Dividend Amidst Q4 Profit Decline
Hester Biosciences announced a ₹7 per share dividend despite a 73.74% drop in Q4 consolidated net profit to ₹13 million. Revenue increased by 4.05% to ₹72 crore, while sales decreased by 5.67%. EBITDA rose 11.29%, but operating profit halved. The company reported a significant increase in other income to ₹8.80 crore, potentially offsetting operational challenges.
Hester Biosciences
1,486.60
-28.30
(-1.87%)
1 Year Returns:-32.16%
Industry Peers
Sun Pharmaceutical
1,700.70
(-1.62%)
Divis Laboratories
6,355.50
(-1.26%)
Torrent Pharmaceuticals
4,003.70
(+1.61%)
Cipla
1,434.50
(-0.95%)
Lupin
2,195.90
(+0.78%)
Dr Reddys Laboratories
1,186.50
(-0.40%)
Mankind Pharma
2,244.40
(+1.38%)
Zydus Life Science
883.75
(-1.88%)
Alkem Laboratories
5,830.50
(-0.56%)
Aurobindo Pharma
1,180.10
(+1.06%)